[1]
2010. BCR ABL KINASE INHIBITORS FOR CANCER THERAPY. International Journal of Pharmaceutical Sciences and Drug Research. 2, 2 (Apr. 2010), 80–90. DOI:https://doi.org/10.25004/IJPSDR.2010.020201.